MedTrace Logo

Treatment of Type 2 Diabetes With Immunonutrients

NCT02462863 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2020-10-01

No results posted yet for this study

Summary

The purpose of this research study is to determine if the nutrients arginine and fish oil will reverse or improve diabetes and to find out what additional good or bad effects a combination of arginine and fish oil may have. Both arginine and fish oil are common nutrients taken by normal people on a frequent basis. However, they have not been used in combination in the proposed doses to reverse diabetes once it is established. This study has been approved by the Food and Drug Administration (FDA investigational new drug \[IND\] 12191).

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DIETARY_SUPPLEMENT

Arginine and fish oil

Dietary supplements

Sponsors & Collaborators

  • Shriners Hospitals for Children

    collaborator OTHER

  • University of Cincinnati

    collaborator OTHER

  • The Christ Hospital

    lead OTHER

Principal Investigators

  • J. Wesley Alexander, M.D., Sc.D. · University of Cincinnati

  • Meenakshi Iyer, M.D. · The Christ Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2017-05-04
Completion
2017-06-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02462863 on ClinicalTrials.gov